Physician profile
Nidaullah Mian
NPI 1700295953
$9,318.38
in general payments reported to CMS, 2019-2025
17 companies · $97.91 in 2025
The $97.91 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,124 · 2020: $678 · 2021: $210 · 2022: $140 · 2023: $67.85 · 2025: $97.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $7,757.17 | 2019-2020 | |
| Abbott Laboratories | $283.41 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $252.44 | 2019-2021 | |
| Acorda Therapeutics, INC | $216.89 | 2019-2020 | |
| Abbvie INC. | $153.64 | 2021-2025 | |
| Greenwich Biosciences, INC. | $128.71 | 2019 | |
| Lundbeck LLC | $110.47 | 2019 | |
| Amgen INC. | $105.13 | 2021-2025 | Uplizna |
| Neurocrine Biosciences, INC. | $82.72 | 2022-2023 | Ongentys, Ingrezza |
| Horizon Therapeutics Plc | $54.39 | 2022 | |
| Allergan, INC. | $38.06 | 2019 | |
| Biogen, INC. | $36.85 | 2021 | |
| Amneal Pharmaceuticals LLC | $27.35 | 2020-2022 | |
| Ucb, INC. | $20.30 | 2022 | |
| Impel Pharmaceuticals INC. | $20.01 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $16.68 | 2020 | |
| Csl Behring | $14.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nidaullah Mian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.